jay campbell retatrutide Learning Peptides from A-Z with

Many patients with diabetes struggle to reach blood pressure targets despite taking multiple antihypertensive medications

Clinical trial evidence from SURMOUNT-1 The landmark SURMOUNT-1 trial, published by Jastreboff and colleagues, provided some of the cleanest data on tirzepatide and hair loss

Rodent studies have shown that systemic or intracerebral administration of GLP-1RAs, such as exendin-4, liraglutide, and semaglutide, significantly reduces intake, preference, and relapse-related behaviors associated with alcohol, cocaine, nicotine, and highly palatable foods rich in fat and sugar value [5,10,24,31]

You dont have Type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease (since Medicare may already cover GLP-1 drugs for those conditions)

Listeners get a balanced take on who might consider creatine and what to discuss with their clinicians